Gedeon Richter is a specialised, innovation-driven pharmaceutical company committed to supporting society in the fight against disease by developing and delivering modern therapies.
A specialised pharmaceutical company Gedeon Richter’s strategic objective is to strengthen its position among Europe’s leading mid-sized pharmaceutical companies.
Gedeon Richter focuses on creating high value-added products, basing its strategy on innovative research and placing a strong emphasis on women’s health and the development of biosimilar medicines.
Research into new molecules has always been at the core of Gedeon Richter’s corporate strategy. The company’s research and development centre, employing more than 1,200 people, makes it the leading pharmaceutical research hub in Central and Eastern Europe.
Gedeon Richter’s portfolio includes over 200 original, generic and licensed therapies used across a wide range of therapeutic areas. The company focuses on developing and manufacturing medicines used in the treatment of disorders of the nervous system, cardiovascular diseases and gynaecology.
Thanks to its in-house production of active pharmaceutical ingredients and a broad product portfolio, Richter delivers innovative therapeutic solutions for women of all ages and with diverse health needs.
At Gedeon Richter, we continuously pursue innovation. At the same time, we believe that through conscious and responsible actions, we can meet the needs of today’s generations while maintaining the trust of those to come.
We are proud that Gedeon Richter represents not only innovative products, but also a stable and supportive workplace guided by the principles of sustainable development.
If you have any questions, please contact us using the appropriate telephone number or email address.
If you have not found the information you were looking for on our website or have additional questions, we encourage you to get in touch with us.
Richter Group
